Vistin Pharma ASA: Prospectus Summary for transfer of listing from Oslo Axess to Oslo Børs

Oslo, Norway, 2 October 2018

Reference is made to the announcement on 26 September 2018 regarding Oslo Børs' resolution to admit the shares in Vistin Pharma ASA to listing on Oslo Børs.

Vistin Pharma ASA today published a Prospectus Summary pursuant to section 7-2 of the Securities Trading Regulation in connection with the Company's transfer of listing from Oslo Axess to Oslo Børs.

Please find the Prospectus Summary attached. The Prospectus Summary will also be made available on www.vistin.com (http://www.vistin.com/).

*****

For further information, please contact:

Gunnar Manum
CFO
[phone]
[e-mail]

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Vistin Pharma ASA Prospectus Summary 30 September 2018 (http://hugin.info/168869/R/2218884/867744.pdf)

---

This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vistin Pharma ASA via Globenewswire